These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18541041)

  • 21. Protocol and methods for testing the efficacy of well-being therapy in chronic migraine patients: a randomized controlled trial.
    Mansueto G; De Cesaris F; Geppetti P; Cosci F
    Trials; 2018 Oct; 19(1):561. PubMed ID: 30326932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preliminary efficacy of aerobic training among university students with migraine symptoms: Study protocol for a pilot randomized controlled trial.
    Selvakumar K; Lee Fan T; Chai Nien F; Hou Kit M
    PLoS One; 2023; 18(9):e0291534. PubMed ID: 37747888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Migraine Progression: A Systematic Review.
    Buse DC; Greisman JD; Baigi K; Lipton RB
    Headache; 2019 Mar; 59(3):306-338. PubMed ID: 30589090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Standardized set-point acupuncture for migraines.
    Plank S; Goodard JL; Pasierb L; Simunich TJ; Croner JR
    Altern Ther Health Med; 2013; 19(6):32-7. PubMed ID: 24254036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acupuncture for migraine and headache in primary care: a protocol for a pragmatic, randomized trial.
    Vickers A; Rees R; Zollman C; Smith C; Ellis N
    Complement Ther Med; 1999 Mar; 7(1):3-18. PubMed ID: 10361566
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methodological quality of randomized controlled trials of spinal manipulation and mobilization in tension-type headache, migraine, and cervicogenic headache.
    Fernández-de-las-Peñas C; Alonso-Blanco C; San-Roman J; Miangolarra-Page JC
    J Orthop Sports Phys Ther; 2006 Mar; 36(3):160-9. PubMed ID: 16596892
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Nursing Intervention Increases Quality of Life and Self-Efficacy in Migraine: A 1-Year Prospective Controlled Trial.
    Leroux E; Beaudet L; Boudreau G; Eghtesadi M; Marchand L; Pim H; Chagnon M
    Headache; 2018 Feb; 58(2):260-274. PubMed ID: 28913825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Galcanezumab for the Prevention of Episodic Migraine: The EVOLVE-1 Randomized Clinical Trial.
    Stauffer VL; Dodick DW; Zhang Q; Carter JN; Ailani J; Conley RR
    JAMA Neurol; 2018 Sep; 75(9):1080-1088. PubMed ID: 29813147
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manual therapy as a prophylactic treatment for migraine: design of a randomized controlled trial.
    Amons AL; Castien RF; van der Wouden JC; De Hertogh W; Dekker J; van der Horst HE
    Trials; 2019 Dec; 20(1):785. PubMed ID: 31881911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Effect of Beginning Treatment With Fremanezumab on Headache and Associated Symptoms in the Randomized Phase 2 Study of High Frequency Episodic Migraine: Post-Hoc Analyses on the First 3 Weeks of Treatment.
    Silberstein SD; Rapoport AM; Loupe PS; Aycardi E; McDonald M; Yang R; Bigal ME
    Headache; 2019 Mar; 59(3):383-393. PubMed ID: 30450545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK; Gawel M; Brandes JL; Pokta S; Vandenburgh AM;
    Headache; 2007 Apr; 47(4):486-99. PubMed ID: 17445098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effect of electroacupuncture with different frequency on headache attacks in migraine outpatients: study protocol for a randomised placebo-controlled trial.
    Nie N; Chen L; Li T; Zhou C; Li B; Ji C; Zhou J; Chen Q; Li Q; Liang Y; Fang J
    Trials; 2021 Jul; 22(1):483. PubMed ID: 34301299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. One-Day Behavioral Intervention for Distressed Veterans with Migraine: Results of a Multimethod Pilot Study.
    Huddleston C; Martin L; Woods K; Dindo L
    Mil Med; 2018 Jul; 183(7-8):e184-e192. PubMed ID: 29420786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcome measures for assessing the effectiveness of non-pharmacological interventions in frequent episodic or chronic migraine: a Delphi study.
    Luedtke K; Basener A; Bedei S; Castien R; Chaibi A; Falla D; Fernández-de-Las-Peñas C; Gustafsson M; Hall T; Jull G; Kropp P; Madsen BK; Schaefer B; Seng E; Steen C; Tuchin P; von Piekartz H; Wollesen B
    BMJ Open; 2020 Feb; 10(2):e029855. PubMed ID: 32051295
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized Controlled Pilot Trial of Behavioral Insomnia Treatment for Chronic Migraine With Comorbid Insomnia.
    Smitherman TA; Walters AB; Davis RE; Ambrose CE; Roland M; Houle TT; Rains JC
    Headache; 2016 Feb; 56(2):276-91. PubMed ID: 26813845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mindfulness and pharmacological prophylaxis after withdrawal from medication overuse in patients with Chronic Migraine: an effectiveness trial with a one-year follow-up.
    Grazzi L; Sansone E; Raggi A; D'Amico D; De Giorgio A; Leonardi M; De Torres L; Salgado-García F; Andrasik F
    J Headache Pain; 2017 Dec; 18(1):15. PubMed ID: 28161874
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
    Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
    Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.
    Mulleners WM; Kim BK; Láinez MJA; Lanteri-Minet M; Pozo-Rosich P; Wang S; Tockhorn-Heidenreich A; Aurora SK; Nichols RM; Yunes-Medina L; Detke HC
    Lancet Neurol; 2020 Oct; 19(10):814-825. PubMed ID: 32949542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.